Concia E - Search Results

1

Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients.

Rigo F, Cucchetto G, Lanzafame M, Nicolè S, Lattuada E, Concia E, Vento S. Rigo F, et al. Among authors: concia e. HIV Med. 2017 Nov;18(10):790-792. doi: 10.1111/hiv.12523. Epub 2017 May 15. HIV Med. 2017. PMID: 28503915 Free article. No abstract available.

2

Virological efficacy of a reduced dose of nevirapine in a small cohort of suppressed HIV-1-infected patients.

Lanzafame M, Lattuada E, Cucchetto G, Nicolè S, Concia E, Vento S. Lanzafame M, et al. Among authors: concia e. J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):e59-61. doi: 10.1097/QAI.0000000000000505. J Acquir Immune Defic Syndr. 2015. PMID: 25559599 No abstract available.

3

Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient.

Lanzafame M, Lattuada E, Nicolè S, Rigo F, Cucchetto G, Concia E, Vento S. Lanzafame M, et al. Among authors: concia e. Int J STD AIDS. 2017 Jun;28(7):726-728. doi: 10.1177/0956462416678164. Epub 2016 Oct 27. Int J STD AIDS. 2017. PMID: 27789848

4

Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings.

Cucchetto G, Lanzafame M, Nicolè S, Lattuada E, Calza L, Concia E. Cucchetto G, et al. Among authors: concia e. J Antimicrob Chemother. 2017 Jul 1;72(7):2138-2140. doi: 10.1093/jac/dkx106. J Antimicrob Chemother. 2017. PMID: 28419270 No abstract available.

5

Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life.

Lattuada E, Lanzafame M, Nicolè S, Rigo F, Cucchetto G, Concia E, Vento S. Lattuada E, et al. Among authors: concia e. Int J STD AIDS. 2018 Feb;29(2):206-207. doi: 10.1177/0956462417747832. Int J STD AIDS. 2018. PMID: 29320967 No abstract available.

6

[CD4+ guided interruption HAART in HIV patients].

Antolini D, Lanzafame M, Lattuada E, Vento S, Concia E. Antolini D, et al. Among authors: concia e. Recenti Prog Med. 2007 Oct;98(10):501-5. Recenti Prog Med. 2007. PMID: 17970175 Italian.

7

[Efficacy and safety of TAM-sparing antiretroviral regimens in naïve HIV-positive patients].

Gottardi M, Lanzafame M, Lattuada E, Soldani F, Boccafoglio F, Concia E. Gottardi M, et al. Among authors: concia e. Infez Med. 2009 Sep;17(3):151-8. Infez Med. 2009. PMID: 19838086 Free article. Clinical Trial. Italian.

8

Disappearance of renal stones in an HIV-1-infected patient after reduction of atazanavir dose.

Lanzafame M, Bonora S, Lattuada E, Calcagno A, Di Perri G, Concia E. Lanzafame M, et al. Among authors: concia e. AIDS Res Hum Retroviruses. 2014 Sep;30(9):835-6. doi: 10.1089/AID.2014.0134. Epub 2014 Jul 31. AIDS Res Hum Retroviruses. 2014. PMID: 24998758 Free article. No abstract available.

9

Efavirenz dose reduction in HIV-infected patients: a long-term follow-up.

Lanzafame M, Lattuada E, Cucchetto G, Concia E, Vento S. Lanzafame M, et al. Among authors: concia e. AIDS. 2014 Nov 28;28(18):2789-90. doi: 10.1097/QAD.0000000000000482. AIDS. 2014. PMID: 25493605 No abstract available.

10

Monoclonal Gammopathy in HIV-Infected Patients on Stable Antiretroviral Therapy: Disappearance or Deep Reduction?

Mazzaferri F, Cordioli M, Lattuada E, Veneri D, Concia E, Lanzafame M. Mazzaferri F, et al. Among authors: concia e. J Acquir Immune Defic Syndr. 2016 May 1;72(1):e11-2. doi: 10.1097/QAI.0000000000000925. J Acquir Immune Defic Syndr. 2016. PMID: 26689973 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters